1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups

Macchia, G., Lazzari, R., Colombo, N., Laliscia, C., Capelli, G., D'Agostino, G. R., Deodato, F., Maranzano, E., Ippolito, E., Ronchi, S., Paiar, F., Scorsetti, M., Cilla, S., Ingargiola, R., Huscher, A., Cerrotta, A. M., Fodor, A., Vicenzi, L., Russo, D., Borghesi, S. & 8 others, Perrucci, E., Pignata, S., Aristei, C., Morganti, A. G., Scambia, G., Valentini, V., Jereczek-Fossa, B. A. & Ferrandina, G., 2020, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups

Macchia, G., Lazzari, R., Colombo, N., Laliscia, C., Capelli, G., D'Agostino, G. R., Deodato, F., Maranzano, E., Ippolito, E., Ronchi, S., Paiar, F., Scorsetti, M., Cilla, S., Ingargiola, R., Huscher, A., Cerrotta, A. M., Fodor, A., Vicenzi, L., Russo, D., Borghesi, S. & 8 others, Perrucci, E., Pignata, S., Aristei, C., Morganti, A. G., Scambia, G., Valentini, V., Jereczek-Fossa, B. A. & Ferrandina, G., 2020, In : Oncologist.

Research output: Contribution to journalArticle

Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis

Gynecologic Cancer InterGroup (GCIG) Meta-analysis Committee, Jan 3 2020, In : JAMA network open. 3, 1, p. e1918939

Research output: Contribution to journalArticle

Open Access

Bevacizumab As Maintenance Treatment in Patients With Ovarian Cancer: Wait for BRCA Testing

Farolfi, A., Lorusso, D., Pignata, S. & De Giorgi, U., Jan 10 2020, In : Journal of Clinical Oncology. 38, 2, p. 172-173 2 p.

Research output: Contribution to journalArticle

Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome

Cecere, S. C., Giannone, G., Salutari, V., Arenare, L., Lorusso, D., Ronzino, G., Lauria, R., Cormio, G., Carella, C., Scollo, P., Ghizzoni, V., Raspagliesi, F., Di Napoli, M., Mazzoni, E., Marchetti, C., Bergamini, A., Orditura, M., Valabrega, G., Scambia, G., Maltese, G. & 7 others, De Matteis, E., Cardalesi, C., Loizzi, V., Boccia, S., Naglieri, E., Scandurra, G. & Pignata, S., 2020, In : Gynecologic Oncology.

Research output: Contribution to journalArticle

2019

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

Matulonis, U. A., Shapira-Frommer, R., Santin, A. D., Lisyanskaya, A. S., Pignata, S., Vergote, I., Raspagliesi, F., Sonke, G. S., Birrer, M., Provencher, D. M., Sehouli, J., Colombo, N., González-Martín, A., Oaknin, A., Ottevanger, P. B., Rudaitis, V., Katchar, K., Wu, H., Keefe, S., Ruman, J. & 1 others, Ledermann, J. A., Jul 1 2019, In : Annals of Oncology. 30, 7, p. 1080-1087 8 p., mdz135.

Research output: Contribution to journalArticle

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

Matulonis, U. A., Shapira-Frommer, R., Santin, A. D., Lisyanskaya, A. S., Pignata, S., Vergote, I., Raspagliesi, F., Sonke, G. S., Birrer, M., Provencher, D. M., Sehouli, J., Colombo, N., González-Martín, A., Oaknin, A., Ottevanger, P. B., Rudaitis, V., Katchar, K., Wu, H., Keefe, S., Ruman, J. & 1 others, Ledermann, J. A., 2019, In : Annals of Oncology. 30, 7, p. 1080-1087 8 p.

Research output: Contribution to journalArticle

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study: Annals of Oncology

Matulonis, U. A., Shapira-Frommer, R., Santin, A. D., Lisyanskaya, A. S., Pignata, S., Vergote, I., Raspagliesi, F., Sonke, G. S., Birrer, M., Provencher, D. M., Sehouli, J., Colombo, N., González-Martín, A., Oaknin, A., Ottevanger, P. B., Rudaitis, V., Katchar, K., Wu, H., Keefe, S., Ruman, J. & 1 others, Ledermann, J. A., 2019, In : Ann. Oncol.. 30, 7, p. 1080-1087 8 p.

Research output: Contribution to journalArticle

BRCA1/2 molecular assay for ovarian cancer patients: A survey through Italian departments of oncology and molecular and genomic diagnostic laboratories

Capoluongo, E., La Verde, N., Barberis, M., Bella, M. A., Buttitta, F., Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Guarneri, V., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S., Radice, P., Ricevuto, E. & 8 others, Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L., Russo, A. & Gori, S., Dec 1 2019, In : Diagnostics. 9, 4, 46.

Research output: Contribution to journalArticle

Open Access

BRCA1/2 molecular assay for ovarian cancer patients: A survey through Italian departments of oncology and molecular and genomic diagnostic laboratories

Capoluongo, E., La Verde, N., Barberis, M., Bella, M. A., Buttitta, F., Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Guarneri, V., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S., Radice, P., Ricevuto, E. & 8 others, Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L., Russo, A. & Gori, S., Dec 1 2019, In : Diagnostics. 9, 4, p. 1-10 10 p., 46.

Research output: Contribution to journalArticle

BRCA1/2 molecular assay for ovarian cancer patients: A survey through Italian departments of oncology and molecular and genomic diagnostic laboratories: Diagnostics

Capoluongo, E., La Verde, N., Barberis, M., Bella, M. A., Buttitta, F., Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Guarneri, V., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S., Radice, P., Ricevuto, E. & 8 others, Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L., Russo, A. & Gori, S., 2019, In : Diagn.. 9, 4

Research output: Contribution to journalArticle

BRCA1/2 molecular assay for ovarian cancer patients: A survey through Italian departments of oncology and molecular and genomic diagnostic laboratories

Capoluongo, E., La Verde, N., Barberis, M., Bella, M. A., Buttitta, F., Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Guarneri, V., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S., Radice, P., Ricevuto, E. & 8 others, Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L., Russo, A. & Gori, S., 2019, In : Diagnostics. 9, 4

Research output: Contribution to journalArticle

BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories

Capoluongo, E., La Verde, N., Barberis, M., Bella, M. A., Buttitta, F., Carrera, P., Colombo, N., Cortesi, L., Gion, M., Guarneri, V., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S., Radice, P., Ricevuto, E., Sapino, A. & 7 others, Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L., Russo, A. & Gori, S., Oct 9 2019, In : Diagnostics. 9, 4

Research output: Contribution to journalArticle

Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M. T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S. C., Maltese, G. & Scambia, G., Dec 2019, In : Gynecologic Oncology. 155, 3, p. 406-412 7 p.

Research output: Contribution to journalArticle

Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M. T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S. C., Maltese, G. & Scambia, G., Dec 2019, In : Gynecologic Oncology. 155, 3, p. 406-412 7 p.

Research output: Contribution to journalArticle

Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial: Gynecologic Oncology

Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M. T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S. C., Maltese, G. & Scambia, G., 2019, In : Gynecol. Oncol.. 155, 3, p. 406-412 7 p.

Research output: Contribution to journalArticle

Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study

Bergamini, A., Cormio, G., Ferrandina, G., Lorusso, D., Giorda, G., Scarfone, G., Bocciolone, L., Raspagliesi, F., Tateo, S., Cassani, C., Savarese, A., Breda, E., De Giorgi, U., Mascilini, F., Candiani, M., Kardhashi, A., Biglia, N., Perrone, A. M., Pignata, S. & Mangili, G., Aug 2019, In : Gynecologic Oncology. 154, 2, p. 323-327 5 p.

Research output: Contribution to journalArticle

Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study

Bergamini, A., Cormio, G., Ferrandina, G., Lorusso, D., Giorda, G., Scarfone, G., Bocciolone, L., Raspagliesi, F., Tateo, S., Cassani, C., Savarese, A., Breda, E., De Giorgi, U., Mascilini, F., Candiani, M., Kardhashi, A., Biglia, N., Perrone, A. M., Pignata, S. & Mangili, G., 2019, In : Gynecologic Oncology. 154, 2, p. 323-327 5 p.

Research output: Contribution to journalArticle

Endometrial cancer stem cells: Role, characterization and therapeutic implications

Giannone, G., Attademo, L., Scotto, G., Genta, S., Ghisoni, E., Tuninetti, V., Aglietta, M., Pignata, S. & Valabrega, G., Nov 2019, In : Cancers. 11, 11, 1820.

Research output: Contribution to journalArticle

Open Access
Open Access

ESMO-ESGO consensus conference recommendations on ovarian cancer: Pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease: International Journal of Gynecological Cancer

Colombo, N., Sessa, C., Bois, A. D., Ledermann, J., McCluggage, W. G., McNeish, I., Morice, P., Pignata, S., Ray-Coquard, I., Vergote, I., Baert, T., Belaroussi, I., Dashora, A., Olbrecht, S., Planchamp, F. & Querleu, D., 2019, In : Int. J. Gynecol. Cancer. 29, 4, p. 728-760 33 p.

Research output: Contribution to journalArticle

ESMO-ESGO consensus conference recommendations on ovarian cancer: Pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease: Annals of Oncology

Colombo, N., Sessa, C., Du Bois, A., Ledermann, J., McCluggage, W. G., McNeish, I., Morice, P., Pignata, S., Ray-Coquard, I., Vergote, I., Baert, T., Belaroussi, I., Dashora, A., Olbrecht, S., Planchamp, F. & Querleu, D., 2019, In : Ann. Oncol.. 30, 5, p. 672-705 34 p.

Research output: Contribution to journalArticle

Genomic Profile and BRCA-1 Promoter Methylation Status in BRCA Mutated Ovarian Cancer: New Insights in Predictive Biomarkers of Olaparib Response

Franzese, E., Centonze, S., Diana, A., Lombardi, A., Carlino, F., Guerrera, L. P., De Vita, F., Caraglia, M., Pignata, S., Ciardiello, F. & Orditura, M., Nov 29 2019, In : Frontiers in Oncology. 9, 1289.

Research output: Contribution to journalArticle

Open Access

Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM)

Giuseppa Vitale, M., Bracarda, S., Cosmai, L., Crocetti, E., Di Lorenzo, G., Lapini, A., Mandressi, A., Martorana, G., Masini, C., Montironi, R., Ortega, C., Passalacqua, R., Porta, C., Procopio, G., Sepe, P., Romano, L., Luigi Pappagallo, G., Conti, G., Guida, M., Martignoni, G. & 4 others, Nolè, F., Pignata, S., Gori, S. & Cartenì, G., 2019, In : Tumori. 105, 4_suppl, p. 3-12 10 p.

Research output: Contribution to journalArticle

Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM)

Giuseppa Vitale, M., Bracarda, S., Cosmai, L., Crocetti, E., Di Lorenzo, G., Lapini, A., Mandressi, A., Martorana, G., Masini, C., Montironi, R., Ortega, C., Passalacqua, R., Porta, C., Procopio, G., Sepe, P., Romano, L., Luigi Pappagallo, G., Conti, G., Guida, M., Martignoni, G. & 4 others, Nolè, F., Pignata, S., Gori, S. & Cartenì, G., 2019, In : Tumori. 105, 4_suppl, p. 3-12 10 p.

Research output: Contribution to journalArticle

Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM)

Giuseppa Vitale, M., Bracarda, S., Cosmai, L., Crocetti, E., Di Lorenzo, G., Lapini, A., Mandressi, A., Martorana, G., Masini, C., Montironi, R., Ortega, C., Passalacqua, R., Porta, C., Procopio, G., Sepe, P., Romano, L., Luigi Pappagallo, G., Conti, G., Guida, M., Martignoni, G. & 4 others, Nolè, F., Pignata, S., Gori, S. & Cartenì, G., 2019, In : Tumori. 105, 4_suppl, p. 3-12 10 p.

Research output: Contribution to journalArticle

Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM).

Giuseppa Vitale, M., Bracarda, S., Cosmai, L., Crocetti, E., Di Lorenzo, G., Lapini, A., Mandressi, A., Martorana, G., Masini, C., Montironi, R., Ortega, C., Passalacqua, R., Porta, C., Procopio, G., Sepe, P., Romano, L., Luigi Pappagallo, G., Conti, G., Guida, M., Martignoni, G. & 4 others, Nolè, F., Pignata, S., Gori, S. & Cartenì, G., Jul 1 2019, In : Tumori. 105, 4_suppl, p. 3-12 10 p.

Research output: Contribution to journalArticle

Olaparib plus bevacizumab as first-line maintenance in ovarian cancer

Ray-Coquard, I., Pautier, P., Pignata, S., Pérol, D., González-Martín, A., Berger, R., Fujiwara, K., Vergote, I., Colombo, N., Mäenpää, J., Selle, F., Sehouli, J., Lorusso, D., Guerra Alía, E. M., Reinthaller, A., Nagao, S., Lefeuvre-Plesse, C., Canzler, U., Scambia, G., Lortholary, A. & 10 others, Marmé, F., Combe, P., De Gregorio, N., Rodrigues, M., Buderath, P., Dubot, C., Burges, A., You, B., Pujade-Lauraine, E. & Harter, P., Dec 19 2019, In : New England Journal of Medicine. 381, 25, p. 2416-2428 13 p.

Research output: Contribution to journalArticle

Olaparib plus bevacizumab as first-line maintenance in ovarian cancer: New England Journal of Medicine

Ray-Coquard, I., Pautier, P., Pignata, S., Pérol, D., González-Martín, A., Berger, R., Fujiwara, K., Vergote, I., Colombo, N., Mäenpää, J., Selle, F., Sehouli, J., Lorusso, D., Guerra Alía, E. M., Reinthaller, A., Nagao, S., Lefeuvre-Plesse, C., Canzler, U., Scambia, G., Lortholary, A. & 10 others, Marmé, F., Combe, P., De Gregorio, N., Rodrigues, M., Buderath, P., Dubot, C., Burges, A., You, B., Pujade-Lauraine, E. & Harter, P., 2019, In : New Engl. J. Med.. 381, 25, p. 2416-2428 13 p.

Research output: Contribution to journalArticle

Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer

Vergote, I., du Bois, A., Floquet, A., Rau, J., Kim, J-W., Del Campo, J. M., Friedlander, M., Pignata, S., Fujiwara, K., Colombo, N., Mirza, M. R., Monk, B. J., Tsibulak, I., Calvert, P. M., Herzog, T. J., Hanker, L. C., Meunier, J., Lee, J-Y., Bologna, A., Carrasco-Alfonso, M. J. & 1 others, Harter, P., Sep 10 2019, In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer: Gynecologic Oncology

Vergote, I., du Bois, A., Floquet, A., Rau, J., Kim, J-W., del Campo, J. M., Friedlander, M., Pignata, S., Fujiwara, K., Colombo, N., Mirza, M. R., Monk, B. J., Tsibulak, I., Calvert, P. M., Herzog, T. J., Hanker, L. C., Meunier, J., Lee, J-Y., Bologna, A., Carrasco-Alfonso, M. J. & 1 others, Harter, P., 2019, In : Gynecol. Oncol.. 155, 2, p. 186-191 6 p.

Research output: Contribution to journalArticle

Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer

Vergote, I., du Bois, A., Floquet, A., Rau, J., Kim, J. W., del Campo, J. M., Friedlander, M., Pignata, S., Fujiwara, K., Colombo, N., Mirza, M. R., Monk, B. J., Tsibulak, I., Calvert, P. M., Herzog, T. J., Hanker, L. C., Meunier, J., Lee, J. Y., Bologna, A., Carrasco-Alfonso, M. J. & 1 others, Harter, P., Nov 1 2019, In : Gynecologic Oncology. 155, 2, p. 186-191 6 p.

Research output: Contribution to journalArticle

Open Access

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., Jul 2019, In : Gynecologic Oncology. 154, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., 2019, In : Gynecologic Oncology. 154, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., 2019, In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Raccomandazioni per l'implementazione del Test genetico BRCA1/2 nelle pazienti con carcinoma ovarico: dall'analisi sul tessuto tumorale a quella su DNA germinale. A cura di: Gruppo di Lavoro SIBioC Biologia Molecolare, Associazione Italiana di Oncologia Medica (AIOM), Società Italiana di Genetica Umana (SIGU), Società Italiana di Anatomia Patologica e Citologia Diagnostica-Divisione Italiana della International Accademy of Pathology (SIAPEC-IAP). Revisione Ottobre 2018.

Translated title of the contribution: Recommendations for the implementation of BRCA1/2 testing in ovarian cancer patients: From tumor to germline analysis. Joint document from SIBioC, AIOM, SIGU, SIAPEC-IAP.Barberis, M., Bella, M. A., Buttitta, F., Capoluongo, E., Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Gori, S., Guarneri, V., Verde, N. L., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S., Radice, P. & 8 others, Ricevuto, E., Russo, A., Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M. & Varesco, L., Jan 1 2019, In : Biochimica Clinica. 43, 3

Research output: Contribution to journalArticle

Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting

Ray-Coquard, I., Trama, A., Seckl, M. J., Fotopoulou, C., Pautier, P., Pignata, S., Kristensen, G., Mangili, G., Falconer, H., Massuger, L., Sehouli, J., Pujade-Lauraine, E., Lorusso, D., Amant, F., Rokkones, E., Vergote, I., Ledermann, J. A., Group, RARECAREN. W. & Mangone, L., 2019, In : European Journal of Surgical Oncology.

Research output: Contribution to journalArticle

Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives: Critical Reviews in Oncology/Hematology

Gori, S., Barberis, M., Bella, M. A., Buttitta, F., Capoluongo, E., Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Guarneri, V., Incorvaia, L., La Verde, N., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S. & 9 others, Radice, P., Ricevuto, E., Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L. & Russo, A., 2019, In : Crit. Rev. Oncol. Hematol.. 140, p. 67-72 6 p.

Research output: Contribution to journalArticle

Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives

Gori, S., Barberis, M., Bella, M. A., Buttitta, F., Capoluongo, E., Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Guarneri, V., Incorvaia, L., La Verde, N., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S. & 9 others, Radice, P., Ricevuto, E., Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L. & Russo, A., Aug 1 2019, In : Critical Reviews in Oncology/Hematology. 140, p. 67-72 6 p.

Research output: Contribution to journalArticle

Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives

Group, AIOM-SIGU-SIBIOC-SIAPEC-IAP. W., Gori, S., Barberis, M., Bella, M. A., Buttitta, F., Capoluongo, E., Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Guarneri, V., Incorvaia, L., La Verde, N., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M. & 10 others, Pignata, S., Radice, P., Ricevuto, E., Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L. & Russo, A., Aug 1 2019, In : Critical Reviews in Oncology/Hematology. 140, p. 67-72 6 p.

Research output: Contribution to journalArticle

Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives: Critical Reviews in Oncology/Hematology

Gori, S., Barberis, M., Bella, M. A., Buttitta, F., Capoluongo, E., Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Guarneri, V., Incorvaia, L., La Verde, N., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S. & 10 others, Radice, P., Ricevuto, E., Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L., Russo, A. & Group, AIOM-SIGU-SIBIOC-SIAPEC-IAP. W., 2019, In : Crit. Rev. Oncol. Hematol.. 140, p. 67-72 6 p.

Research output: Contribution to journalArticle

Safety and efficacy of nivolumab for metastatic renal cell carcinoma

De Giorgi, U., Cartenì, G., Giannarelli, D., Basso, U., Galli, L., Cortesi, E., Caserta, C., Pignata, S., Sabbatini, R., Bearz, A., Buti, S., Lo Re, G., Berruti, A., Bracarda, S., Cognetti, F., Rastelli, F., Fornarini, G., Porta, C., Turci, D., Sternberg, C. N. & 1 others, Procopio, G., 2019, In : BJU International.

Research output: Contribution to journalArticle